Article

Judging Osteoporosis Screening Intervals From the Latest T Score

(AUDIO) Data from a long-term prospective study reveal that, for many older women, the pace of bone mass deterioration takes place on the scale of decades, not single years. Here, the lead author of the study describes how to interpret the results to choose the date for your own patient's next bone-density test.

 

(AUDIO) Among women with normal initial bone mass who took part in a major osteoporosis study, only 10% developed osteoporosis within 15 years. What are the implications of this knowledge for best practices in osteoporosis screening? Dr Margaret Gourlay, lead author of the report in the New England Journal of Medicine, tells what you should take into account as you work with patients to decide how often they need a bone-density test. Dr Gourlay is Assistant Professor of Family Medicine at the University of North Carolina at Chapel Hill.

 

Judging Osteoporosis Screening Intervals from the Latest T Score

 For your reference:

Osteoporosis Study Suggests Bone Density Testing Intervals for Older WomenMusculoskeletal Network, January 31, 2012

Bone-Density Testing Interval and Transition to Osteoporosis in Older Women
Gourlay ML, Fine JP, et al. New England Journal of Medicine, January 19, 2012

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.